Home Biotechnology Diamyd Medical
D

Diamyd Medical

Profile managed by Bizz Id

Diamyd Medical AB

Suecia 11-50 employees
Biotechnology CRO
Claim this profile

Description

Swedish clinical-stage type 1 diabetes company (Nasdaq First North). Develops Diamyd®, a GAD-alum precision immunotherapy that preserves insulin production in HLA DR3-DQ2 patients. Phase III (DIAGNODE-3) ongoing at 60 clinics in 8 countries.

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free

We only use technical cookies that are necessary for the site to work and to keep you signed in. We do not use analytics or advertising cookies. Cookies